Beijing Nine Strong Biological Technology Co., Ltd.
Announcement on Termination of Share Transfer Agreement by Shareholders
The Company and all members of its board of directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Beijing Nine Strong Biological Technology Co., Ltd. (hereinafter referred to as the "Company") recently received a letter from Mr. Zou Zuojun, Mr. Liu Xi, and Mr. Sun Xiaolin (hereinafter collectively referred to as the "Transferors" or "Party A") to China National Pharmaceutical Industry Corporation (hereinafter referred to as "Sinopharm Investment" or "Transferee" or "Party B"). The letter stated that the proposed transfer of 29,315,433 unrestricted tradable shares of the Company (5.0000003% of the Company's total share capital, and 5.0304078% of the total share capital after deducting repurchased shares) by the Transferors to the Transferee through an agreement transfer has been terminated. The relevant matters are hereby announced as follows:
I. Basic情况 of the Agreement Transfer